于 佳, 今井 康人, 野村 章洋, 米田 隆, 村山 敏典. 日本国内での新型コロナウイルス感染症のパイロット観察研究における電子同意書の使用(Use of Electronic Consent Forms in an Observational Pilot Study of Coronavirus Disease in Japan). 薬理と治療. 2022. 50. Suppl.2. s154-s165
Hiroshi Wakabayashi, Anri Inaki, Kenichi Yoshimura, Toshinori Murayama, Yasuhito Imai, Tetsuya Higuchi, Megumi Jinguji, Tohru Shiga, Seigo Kinuya. Author Correction: A phase I clinical trial for [131I]meta-iodobenzylguanidine therapy in patients with refractory pheochromocytoma and paraganglioma. Scientific Reports. 2022. 12. 1. 1347-1347
Rie Kuroda, Hiroshi Wakabayashi, Raita Araki, Anri Inaki, Ryosei Nishimura, Yasuhiro Ikawa, Kenichi Yoshimura, Toshinori Murayama, Yasuhito Imai, Tatsuyoshi Funasaka, et al. Phase I/II clinical trial of high-dose [131I] meta-iodobenzylguanidine therapy for high-risk neuroblastoma preceding single myeloablative chemotherapy and haematopoietic stem cell transplantation. European journal of nuclear medicine and molecular imaging. 2022. 49. 5. 1574-1583
Shizuko Takahara, Toshiki I Saito, Yasuhito Imai, Takahiro Kawakami, Toshinori Murayama. A use-case analysis of Clinical Data Interchange Standards Consortium/Study Data Tabulation Model in academia in an investigator-initiated clinical trial. Nagoya journal of medical science. 2022. 84. 1. 120-132
Akihiko Takeuchi, Makoto Endo, Akira Kawai, Yoshihiro Nishida, Ryu Terauchi, Akihiko Matsumine, Hisaki Aiba, Tomoki Nakamura, Susumu Tandai, Toshifumi Ozaki, et al. Randomized placebo-controlled double-blind phase II study of zaltoprofen for patients with diffuse-type and unresectable localized tenosynovial giant cell tumors: The REALIZE study. Frontiers in oncology. 2022. 12. 900010-900010
